Developing targeted vaccines to enhance antibody responses
Creating high-resolution, epitope-focused vaccines
This study is working on new vaccines that aim to train your immune system to fight off viruses like HIV, Ebola, and the flu by focusing on specific parts of these viruses, so you can have better protection against different strains.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-10904972 on NIH RePORTER |
What this research studies
This research aims to create innovative vaccines that specifically target certain parts of viruses, known as epitopes, to generate a strong immune response. By focusing on these key areas, the vaccines are designed to produce neutralizing antibodies that can effectively combat infectious diseases like HIV, Ebola, and influenza. The approach utilizes broadly neutralizing monoclonal antibodies as a foundation, which have shown promise in clinical trials. If successful, this method could lead to vaccines that provide broad protection against various strains of these viruses.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for infections caused by HIV, Ebola, or influenza, who may benefit from enhanced vaccine responses.
Not a fit: Patients with existing immunity or those who have already been vaccinated against these viruses may not receive additional benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective vaccines that provide better protection against infectious diseases.
How similar studies have performed: Other research has shown promise in using monoclonal antibodies for vaccine development, indicating that this approach has potential for success.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Kim, Peter S — Stanford University
- Study coordinator: Kim, Peter S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.